InBody Co (041830.KQ) Stock Price

InBody Co Price

KOSDAQ·CLOSED
46,850.00
​
Market closed

Over the last 19 years InBody Co grew revenue by 16.9% annually, reaching 233.95 B KRW. Earnings per share have grown at 28.6% per year over the last 19 years. For InBody Co, the net margin of 13.1% is down versus 24.7% a few years ago. At today's price the dividend yield works out to roughly 0.85%. The payout ratio is around 16% of earnings. The dividend has grown at 16.7% per year over the past 18 years. The consensus 12-month price target for InBody Co is 37,740.00 KRW, about 19.4% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

InBody Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InBody Co business model & stock analysis

InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration.

Frequently asked questions about InBody Co

Analysts currently set an average price target of 37,740.00 KRW for the InBody Co stock (median: 37,740.00 KRW), implying -19.4 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the InBody Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect InBody Co to generate revenue of 285.63 B KRW and earnings per share of 3,931.70 KRW.

Converted at the current exchange rate, the InBody Co share trades at 31.57 EUR (46,850.00 KRW).

The InBody Co share (041830.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (041830.KQ).

The expected revenue of InBody Co is 285.63 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of InBody Co is 47.94 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of InBody Co is currently 11.92. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the InBody Co stock.

The price-to-sales ratio (P/S) of InBody Co is currently 2.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the InBody Co stock.

The Eulerpool Quality Score for InBody Co is 7/10.

The ISIN of InBody Co is KR7041830001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of InBody Co is 041830.KQ. The ticker symbol is used to trade InBody Co shares on the stock exchange.

Fair ValueTerminal
47,787.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website inbody.co.kr
Country
South Korea
Currency
KRW
Initial public offering
Dec 14, 2000
ISIN
KR7041830001
Cusip
Y0894V103
Market capitalization
607.25 B KRWMega Cap
52-Week Range
PEG
1.82
P/E ratio
P/Ee 2026
12.67
P/Ee 2027
11.17
P/Ee 2028
9.45
P/S
P/Se
2.00
EV/EBIT
16.52
P/B Ratio
1.91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.64 %
Dividend
Dividend yield
0.85 %
Est. Dividend Yield
1.28 %
Payout Ratio
15.92 %
Dividend growth Ø5Y
14.87 %
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
22.00 %
Last updated Oct 25, 2026, 2:44 AM

InBody Co Peer Group

InBody Co Ticker

KOSDAQ · 041830.KQ

InBody Co FIGI

041830:KS · BBG000F001C6041830:KQ · BBG000F00298

All fundamentals and in-depth analysis of InBody Co

Our stock analysis for InBody Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InBody Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.